258P Analysis of patients (pts) without an initial triple-negative breast cancer (TNBC) diagnosis (Dx) in the phase III ASCENT study of sacituzumab govitecan (SG) in brain metastases-negative (BMNeg) metastatic TNBC (mTNBC)

Authors :: S. Phan
Kevin Kalinsky
Joyce O'Shaughnessy
Tiffany A. Traina
Kevin Punie
Adam Brufsky
J. Cortés
Ingrid A. Mayer
Aditya Bardia
Delphine Loirat
Sami Diab
Q. Hong
R. Leon-Ferre
Hope S. Rugo
Sara A. Hurvitz
Erika Hamilton
Sara M. Tolaney
Stéphanie Henry
Sagar Sardesai
Source :: Annals of Oncology. 32:S473-S474
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Internal medicine
Sacituzumab govitecan
Medicine
Hematology
business
Triple-negative breast cancer

Tools